ConductScience.org, home

Trial · NCT03825887

Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients

NCT03825887, Phase 3, Completed, Children's Cancer Hospital Egypt 57357

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients. Trials, record NCT03825887. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03825887

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients
NCT number
NCT03825887
Status
Completed
Phases
Phase 3
Enrollment
80 participants, actual
Lead sponsor
Children's Cancer Hospital Egypt 57357
Conditions
Acute Myeloid Leukemia, Stem Cell Leukemia
Interventions
Nalbuphine, Morphine
First posted
2019-01-31
Last updated
2021-08-02

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarymeasure the change in Pain intensitychange occur every 12 hours and during the performing of mouth care for each patient over the first 7 dayschange in pain intensity by visual analogue scale (scale from 0 to 100)
PrimaryTotal opioid consumptionsthe total consumption through the entire 7 days since initiationtotal dosing in mg/day
SecondaryNumber of active and total pushes of PCA buttonsevery 24 hours and the sum up of the active and total pushes of PCA buttons for each patient over the 7 days.Number of active and total pushes of PCA buttons
SecondaryPatient satisfaction: linear scaleat the end of the 7 days.Patient satisfaction score PSS was assessed using a linear scale where 0=very satisfied; 10=very dissatisfied (14).
SecondaryAssess serious adverse eventsduring 7 days of treatment onlyby reporting the number of patients with Nausea and vomiting and/or pruritus and/or respiratory depression and/or urinary retention and/or sedation and/or bradycardia and/or hypotension).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03825887

GET https://conductscience.org/api/trials/v1/NCT03825887/registered